Citations

Showing 10 of 108081 citations.

Availability of Network Psychiatrists Among the Largest Health Insurance Carriers in Washington, D.C.
Blech, Benzion , West, Joyce C. , Yang, Zhuoyin, Barber, Keila D., Wang, Philip , Coyle, Colleen

Mayo Clinic

Psychiatric Services | May 1, 2017 | Volume: 68 | Issue: 9 | Pages: 962-965

10.1176/appi.ps.201600454 | PMID 28457210 Get It

Focal adhesion kinase inhibitor PF573228 and death receptor 5 agonist lexatumumab synergistically induce apoptosis in pancreatic carcinoma
Zhao, Xiangxuan , Puszyk, William, Wallet, Shannon M. , Hochwald, Steve, Robertson, Keith D. , Liu, Chen , Robertson, Keith, Sun, Wei , Robertson, Keith D , Liu, Chen

Mayo Clinic

Tumor Biology | May 1, 2017 | Volume: 39 | Issue: 5 | Pages: 101042831769912

10.1177/1010428317699120 | PMID 28459212 Get It

Pancreatic cancer has one of the lowest survival rates of all cancers. The mechanism underlying chemo-resistance of pancreatic cancer is not well understood. Our previous article reported that small molecule YM155 induced apoptosis in pancreatic cancer cells via activation of death receptor 5. In this study, we aim to continuously address death receptor 5–mediated apoptosis in chemo-resistant pancreatic carcinoma. We found that in comparison to paired pancreatic cancer tissues and adjacent normal tissues, five of the six cancer tissues had downregulated death receptor 5 and upregulated Bcl-xL. Mono treatment with lexatumumab was not sufficient to induce apoptosis in pancreatic cancer cells, whereas focal adhesion kinase inhibitor PF573228 significantly sensitized lexatumumab-induced apoptosis. Western blotting analysis revealed that lexatumumab and PF573228 combination treatment increased death receptor 5 but decreased Bcl-xL expression. Interestingly, pre-treatment with Bcl-xL inhibitor ABT263 reversed the insensitivity of panc-1 cells to lexatumumab or PF573228-induced apoptosis. Specific small interfering RNA-mediated gene silencing of Bcl-xL effectively sensitized pancreatic cancer cells to lexatumumab or PF573228-induced apoptosis. Furthermore, lexatumumab and PF573228 combination was shown to exhibit significant xenograft pancreatic tumor growth inhibition in SCID mice. Our data provide fundamental evidence to support the notion that lexatumumab and PF573228 co-treatment could be a potentially effective regime for patients with pancreatic cancer.
Detecting fasciculations in cranial nerve innervated muscles with ultrasound in amyotrophic lateral sclerosis
O’Gorman, Cullen , Weikamp, Janneke G. , Baria, Michael R. , Engel–Hoek, L. van den , Kassardjian, Charles D. , Boon, Andrea J. , O'gorman, Cullen M , Van Den Engel-Hoek, Lenie , Kassardjian, Charles, Alfen, Nens van

Mayo Clinic

Muscle & Nerve | April 30, 2017 | Volume: 56 | Issue: 6 | Pages: 1072-1076

10.1002/mus.25676 | PMID 28457000 Get It

ABSTRACTIntroductionCranial muscle fasciculations may be difficult to detect in amyotrophic lateral sclerosis (ALS). Ultrasound (US) detection of fasciculations in these muscles may have clinical utility.MethodsPatients with suspected ALS were prospectively enrolled. Nerve conduction studies, needle electromyography (EMG), and US examination of cranial muscles were performed. Controls were examined by US only. Fasciculations were counted and scored for each muscle after 10 or 30 seconds.ResultsThere were 84 patients with ALS. Fasciculations were most frequently found in the genioglossus muscle. Overall, detection rates by US and EMG were similar, but US was more likely to detect frequent fasciculations. Fasciculations were rare in controls, seen in 7 of 1,090 (0.6%) muscles. No control had > 5 fasciculations in any muscle.DiscussionFasciculations were frequently detected in cranial muscles of patients with ALS. US was found to be a sensitive method, and was not impaired by factors such as anxiety and the inability of the patient to relax. Muscle Nerve 56: 1072–1076, 2017
Skeletal Muscle Involvement in B-Cell Lymphoma: Two Cases Illustrating the Contribution of Imaging to a Clinically Unsuspected Diagnosis
Burton, Elijah , Schafernak, Kristian T. , Schafernak, Kristian, Morgan, Elaine R. , Samet, Jonathan D. , Schafernak, Kristian

Mayo Clinic

Case Reports in Radiology | April 30, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-7

10.1155/2017/2068957 | PMID 28540097 Get It

Skeletal muscle lymphoma is rare, comprising only a very small subset of lymphoma cases. There are characteristic imaging features which, if recognized, can prevent delay in diagnosis and treatment, particularly when not suspected clinically. Herein, we report two cases of skeletal muscle lymphoma with nearly identical imaging features; the first is an example of primary muscle lymphoma in a 17-year-old boy with back and thigh pain, and the second represents lymphoma recurrence in a 55-year-old man with HIV. Characteristic features seen on MRI were key in raising suspicion for the disease and helped prevent a delay in pathologic diagnosis.
A multidisciplinary approach to reducing alarm fatigue and cost through appropriate use of cardiac telemetry
Alsaad, Ali A. , Alman, Carly R, Thompson, Kristine M., Monteau, Rebecca E. , Park, Shin H, Maniaci, Michael J. , Park, Shin Ho

Mayo Clinic

Postgraduate Medical Journal | April 29, 2017 | Volume: 93 | Issue: 1101 | Pages: 430-435

10.1136/postgradmedj-2016-134764 | PMID 28455284 Get It

ABSTRACTBackgroundAlarm fatigue (AF) is a distressing factor for staff and patients in the hospital. Using cardiac telemetry (CT) without clinical indications can create unnecessary alarms, and increase AF and cost of healthcare. We sought to reduce AF and cost associated with CT monitoring.MethodsAfter implementing a new protocol for CT placement, data were collected on telemetry orders, alarms and bed cost for 13 weeks from 1 January 2015 through 31 March 2015. We also retrospectively collected data on the same variables for the 13 weeks prior to the intervention. A survey was administered to nurses to assess past and present perceptions of AF. Interventions included protocol creation and education for participants.ResultsAt baseline, 77% of patients were monitored with CT. A total of 145 (31%) order discrepancies were discovered during data collection, of which 72% had no indication for CT, so CT was discontinued. The other 28% had indications, so orders were placed. A total of 8336 alarms were recorded during 4 weeks of data collection, of which 333 (4%) were classified as true actionable alarms. Postintervention data showed 67% CT assignment with 10% reduction in CT usage, with no increase in mortality (p<0.001 and >0.05, respectively). A 42% cost reduction was achieved after adjusting the patient status. Nurses reported 27% perceived reduction in AF. One-year follow-up revealed that 69% of patients were being monitored by CT, and the rate of order discrepancies due to lack of indication was 9%.ConclusionAll hospital units may benefit from the protocols created during this study. If applied appropriately, these protocols can lead to reduced AF and cost per episode of care.
Recessive TAF1A mutations reveal ribosomopathy in siblings with end-stage pediatric dilated cardiomyopathy
Long, Pamela A., Theis, Jeanne L. , Shih, Yu‐Huan, Maleszewski, Joseph J. , Aleff, Patrice C. Abell, Evans, Jared M., Olson, Timothy M. , Xu, Xiaolei , Theis, Jeanne L , Olson, Timothy M

Mayo Clinic

Human Molecular Genetics | April 28, 2017 | Volume: 26 | Issue: 15 | Pages: 2874-2881

10.1093/hmg/ddx169 | PMID 28472305 Get It

CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Wang, Dingzhi , Sun, Haiyan , Wei, Jie , Cen, Bo , DuBois, Raymond N.

Mayo Clinic

Cancer Research | April 28, 2017 | Volume: 77 | Issue: 13 | Pages: 3655-3665

10.1158/0008-5472.can-16-3199 | PMID 28455419 Get It

Abstract Emerging evidence suggests that the primary tumor influences the development of supportive metastatic microenvironments, referred to as premetastatic niches, in certain distant organs before arrival of metastatic cells. However, the mechanisms underlying the contributions of the primary tumor to premetastatic niche formation are not fully understood. Here, we demonstrate that colorectal carcinoma cells secrete VEGFA, which stimulates tumor-associated macrophages to produce CXCL1 in the primary tumor. Elevation of CXCL1 in premetastatic liver tissue recruited CXCR2-positive myeloid-derived suppressor cells (MDSC) to form a premetastatic niche that ultimately promoted liver metastases. Importantly, premetastatic liver-infiltrating MDSCs induced tumor cell survival without involvement of innate or adaptive immune responses. Our study provides the first evidence that primary malignant cell-secreted VEGFA stimulates tumor-associated macrophages to produce CXCL1, which recruits CXCR2-positive MDSCs to form a premetastatic niche to promote liver metastases. Our findings not only shed light on how the tumor microenvironment contributes to premetastatic niche formation at distant sites, but they also provide comprehensive insights into how MDSCs are recruited to other organs where they contribute to metastatic spread of disease. Moreover, our work also provides a rationale for development of CXCR2 antagonists to inhibit or prevent metastatic spread of disease. Cancer Res; 77(13); 3655–65. ©2017 AACR.
Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment
Weinstein, Aliyah M. , Chen, Lu , Brzana, Emily A., Patil, Prashanti , Taylor, Jennifer L. , Fabian, Kellsye P. , Wallace, Callen T. , Jones, Sabrina D. , Watkins, Simon C. , Lu, Binfeng , Stroncek, David F. , Denning, Timothy L. , Cohen, Peter A. , Storkus, Walter J. , Fu, Yang‐Xin

Mayo Clinic

OncoImmunology | April 28, 2017 | Volume: 6 | Issue: 6 | Pages: No page available

10.1080/2162402x.2017.1322238 | PMID 28680760 Get It

The role of revision surgery and adjuvant therapy following subtotal resection of osteosarcoma of the spine: a systematic review with meta-analysis
Shankar, Ganesh M. , Rhines, Laurence D. , Patel, Shreyaskumar , Sahgal, Arjun , Laufer, Ilya , Chou, Dean , Sciubba, Daniel M. , Fehlings, Michael G. , Fisher, Charles G. , Gokaslan, Ziya L. , Shin, John H. , Clarke, Michelle J. , Ailon, Tamir T. , Bilsky, Mark H. , Fehlings, Michael G

Mayo Clinic

Journal of Neurosurgery: Spine | April 28, 2017 | Volume: 27 | Issue: 1 | Pages: 97-104

10.3171/2016.12.spine16995 | PMID 28452631 Get It

OBJECTIVEPrimary osteosarcoma of the spine is a rare osseous neoplasm. While previously reported retrospective studies have demonstrated that overall patient survival is impacted mostly by en bloc resection and chemotherapy, the continued management of residual disease remains to be elucidated. This systematic review was designed to address the role of revision surgery and multimodal adjuvant therapy in cases in which en bloc excision is not initially achieved.METHODSA systematic literature search spanning the years 1966 to 2015 was performed on PubMed, Medline, EMBASE, and Web of Science to identify reports describing outcomes of patients who underwent biopsy alone, neurological decompression, or intralesional resection for osteosarcoma of the spine. Studies were reviewed qualitatively, and the clinical course of individual patients was aggregated for quantitative meta-analysis.RESULTSA total of 16 studies were identified for inclusion in the systematic review, of which 8 case reports were summarized qualitatively. These studies strongly support the role of chemotherapy for overall survival and moderately support adjuvant radiation therapy for local control. The meta-analysis revealed a statistically significant benefit in overall survival for performing revision tumor debulking (p = 0.01) and also for chemotherapy at relapse (p < 0.01). Adjuvant radiation therapy was associated with longer survival, although this did not reach statistical significance (p = 0.06).CONCLUSIONSWhile the initial therapeutic goal in the management of osteosarcoma of the spine is neoadjuvant chemotherapy followed by en bloc marginal resection, this objective is not always achievable given anatomical constraints and other limitations at the time of initial clinical presentation. This systematic review supports the continued aggressive use of revision surgery and multimodal adjuvant therapy when possible to improve outcomes in patients who initially undergo subtotal debulking of osteosarcoma. A limitation of this systematic review is that lesions amenable to subsequent resection or tumors inherently more sensitive to adjuvants would exaggerate a therapeutic effect of these interventions when studied in a retrospective fashion.
Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients with Sepsis: A Preliminary Investigation
Guirgis, Faheem W. , Dodani, Sunita , Moldawer, Lyle L. , Leeuwenburgh, Christiaan , Bowman, Jennifer, Kalynych, Colleen , Jones, Alan E. , Reddy, Srinivasa T. , Moore, Frederick A.

Mayo Clinic

Shock | April 28, 2017 | Volume: 48 | Issue: 5 | Pages: 539-544

10.1097/shk.0000000000000887 | PMID 28452909 Get It

ABSTRACT Background: High density lipoprotein (HDL) can be readily oxidized in inflammatory conditions and exhibit pro-inflammatory and dysfunctional (Dys-HDL) characteristics. We hypothesize that Dys-HDL may predict adverse outcomes and correlate with inflammatory cytokines in sepsis. Methods: Emergency department (ED) patients with sepsis were enrolled. Blood was drawn at enrollment and after 48 h. Dys-HDL, expressed as HDL inflammatory index (HII), and cytokines were measured. Multivariable logistic regression was used to determine the predictive ability of Dys-HDL for adverse outcomes (death, discharge to hospice, or nursing home). Results: Thirty-five patients were included in the study. HII was not significantly different at baseline or 48 h between patients with adverse outcomes versus those without. However, there was a significant difference in change in HII over the first 48 h between those with adverse outcomes (+0.21, 95% CI −0.13 to 0.31) versus those without (−0.11, 95% CI −1 to 0.11) (P = 0.025). Logistic regression revealed increasing HII to be an independent predictor of adverse outcomes (OR 5.2, 95% CI 1.1–25.1 P = 0.040). Of the 24 patents with cytokine measurements at both time points, significant inverse correlations between change in HII and change in GRO (rs = −0.52, P = 0.0088) and monocyte chemotactic protein-1 (rs = −0.61, P = 0.0014) concentrations over 48 h were observed. Conclusion: Increasing Dys-HDL concentrations in the first 48 h of sepsis are associated with an ongoing inflammatory response and adverse clinical outcomes. Early changes in HII may be a potential biomarker in ED patients admitted with sepsis.